COCP Stock: Coronavirus Drug Licensing and $11 Million Direct Offering

COCP stock took off early this week and investors are keeping a close watch. However, why did this happen to begin with? Cocrystal Pharma (Nasdaq: COCP) announced a licensing agreement with the Kansas State University Research Foundation (KSURF) for coronavirus drug candidates. With rising concerns over the virus, Cocrystal is looking to progress its research […]